Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


SSP Of Japan Now 93 Percent Owned By German Drug Maker

This article was originally published in PharmAsia News

Executive Summary

Japan's SSP has become at least 93 percent owned by German drug maker Boehringer Ingelheim, almost enough to make SSP part of a holding company of the investor. SSP is Japan's third-largest producer of over-the-counter drugs, specializing in those considered easy to take. Boehringer Ingelheim expects to increase its stake in SSP to nearly 94 percent, at which point the German firm would take SSP off the stock market. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts